Eledon Pharmaceuticals (ELDN) Return on Assets [ROA] (2014 - 2026)
Eledon Pharmaceuticals (ELDN) reported Return on Assets [ROA] of -64.42% for Q2 2026, down 7.01 percentage points from -57.41% a year earlier and down 11.86 percentage points from the prior quarter.
Powered by 
Analysis
Eledon Pharmaceuticals (ELDN) Return on Assets [ROA] (2014 - 2026) Analysis & Trends
For FY2025, Eledon Pharmaceuticals posted Return on Assets [ROA] of -26.34%, up 0.82 percentage points from FY2024.
- Return on Assets [ROA] has a five-year change of -4.42 percentage points (FY2020 to FY2025).
- By year, Return on Assets [ROA] came in at -27.16% in FY2024 (+101.00 pp), -128.16% in FY2023 (-61.35 pp), -66.81% in FY2022 (-48.04 pp) and -18.77% in FY2021 (+3.15 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Assets [ROA] since Q3 2023.
- Year over year, Return on Assets [ROA] gained in two of the last seven quarters, with an average year-over-year change of +0.70 percentage points.
- The high point for year-over-year Return on Assets [ROA] in five years was Q1 2024 (a gain of 51.56 percentage points); the low point was Q1 2023 (a drop of 80.29 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Eledon Pharmaceuticals | 313.62 Mn | 224.82 Mn | - | -74.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -74.14% |
| Mar 31, 2026 | -48.14% |
| Sep 30, 2025 | -44.80% |
| Jun 30, 2025 | -41.14% |
| Mar 31, 2025 | -57.07% |
| Dec 31, 2024 | -77.91% |
| Sep 30, 2024 | -84.56% |
| Jun 30, 2024 | -89.49% |
| Mar 31, 2024 | -65.36% |
| Dec 31, 2023 | -46.45% |
| Sep 30, 2023 | -89.77% |
| Jun 30, 2023 | -95.53% |
| Mar 31, 2023 | -101.90% |
| Dec 31, 2022 | -72.59% |
| Sep 30, 2022 | -25.23% |
| Jun 30, 2022 | -23.88% |
| Mar 31, 2022 | -21.61% |
| Dec 31, 2021 | -19.85% |
| Sep 30, 2021 | -17.71% |
| Jun 30, 2021 | -15.07% |
API Access
Eledon Pharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ELDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ELDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ELDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();